These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 28389174

  • 21. Inhibition of interleukin-5 induced false positive anti-drug antibody responses against mepolizumab through the use of a competitive blocking antibody.
    Liao K, Meyer E, Lee TN, Loercher A, Sikkema D.
    J Immunol Methods; 2017 Feb; 441():15-23. PubMed ID: 27889561
    [Abstract] [Full Text] [Related]

  • 22. Evaluation of a generic immunoassay with drug tolerance to detect immune complexes in serum samples from cynomolgus monkeys after administration of human antibodies.
    Stubenrauch K, Wessels U, Essig U, Vogel R, Schleypen J.
    J Pharm Biomed Anal; 2010 Jun 05; 52(2):249-54. PubMed ID: 20083366
    [Abstract] [Full Text] [Related]

  • 23. Addressing Domain Specificity in the Development of a Cell-Based Binding Assay for the Detection of Neutralizing Antibodies Against a CD47xPD-L1 Bispecific Antibody.
    Luong M, Wang Y, Donnelly BB, Lepsy C.
    AAPS J; 2023 Sep 22; 25(6):91. PubMed ID: 37740131
    [Abstract] [Full Text] [Related]

  • 24. Development of a Cell-based Neutralizing Antibody Assay for Zinpentraxin Alfa: Challenges and Mitigation Strategies.
    Yin Z, Guerrero J, Melendez R, Andrews B, Peng K.
    AAPS J; 2023 Jul 20; 25(5):75. PubMed ID: 37468730
    [Abstract] [Full Text] [Related]

  • 25. Solution ELISA as a platform of choice for development of robust, drug tolerant immunogenicity assays in support of drug development.
    Mikulskis A, Yeung D, Subramanyam M, Amaravadi L.
    J Immunol Methods; 2011 Feb 28; 365(1-2):38-49. PubMed ID: 21130095
    [Abstract] [Full Text] [Related]

  • 26. Comparison of different immunoassay methods to detect human anti-drug antibody using the WHO erythropoietin antibody reference panel for analytes.
    Shibata H, Nishimura K, Miyama C, Tada M, Suzuki T, Saito Y, Ishii-Watabe A.
    J Immunol Methods; 2018 Jan 28; 452():73-77. PubMed ID: 28970009
    [Abstract] [Full Text] [Related]

  • 27. Isotyping and Semi-Quantitation of Monkey Anti-Drug Antibodies by Immunocapture Liquid Chromatography-Mass Spectrometry.
    Huang X, Xu X, Partridge MA, Chen J, Koehler-Stec E, Sumner G, Qiu H, Torri A, Li N.
    AAPS J; 2021 Jan 06; 23(1):16. PubMed ID: 33404777
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Pharmacokinetic studies of recombinant human insulin-like growth factor I (rhIGF-I)/rhIGF-binding protein-3 complex administered to patients with growth hormone insensitivity syndrome.
    Camacho-Hübner C, Rose S, Preece MA, Sleevi M, Storr HL, Miraki-Moud F, Minuto F, Frystyk J, Rogol A, Allan G, Sommer A, Savage MO.
    J Clin Endocrinol Metab; 2006 Apr 06; 91(4):1246-53. PubMed ID: 16403822
    [Abstract] [Full Text] [Related]

  • 31. Development of Immunocapture-LC/MS Assay for Simultaneous ADA Isotyping and Semiquantitation.
    Chen LZ, Roos D, Philip E.
    J Immunol Res; 2016 Apr 06; 2016():7682472. PubMed ID: 27034966
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Calibration-free concentration analysis for quantification of anti-drug specific antibodies in polyclonal positive control antibodies and in clinical samples.
    Aniol-Nielsen C, Toft-Hansen H, Dahlbäck M, Nielsen CH, Solberg H.
    J Immunol Methods; 2021 Oct 06; 497():113002. PubMed ID: 33640327
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Assay development considerations to improve drug tolerance in direct competitive ligand binding neutralizing antibody assays, pretreatment strategies.
    Rathi A, Rinker S, Niu H, Carter C, Kumar S, Cowan K.
    J Immunol Methods; 2023 Jun 06; 517():113484. PubMed ID: 37116778
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Recommendations for the characterization of immunogenicity response to multiple domain biotherapeutics.
    Gorovits B, Wakshull E, Pillutla R, Xu Y, Manning MS, Goyal J.
    J Immunol Methods; 2014 Jun 06; 408():1-12. PubMed ID: 24861938
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.